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Thymocytes undergo massive proliferation before T
cell receptor (TCR) gene rearrangement, ensuring
the diversification of the TCR repertoire. Because ac-
tivated cells are more susceptible to damage, cell-
death restraint as well as promotion of cell-cycle pro-
gression is considered important for adequate cell
growth. Although the molecular mechanism of pre-
TCR-induced proliferation has been examined, the
mechanisms of protection against cell death during
the proliferation phase remain unknown. Here we
show that the survival of activated pre-T cells in-
duced by pre-TCR signaling required the Polycomb
group (PcG) gene product Bmi-1-mediated repres-
sion of Cdkn2A, and that p19Arf expression resulted
in thymocyte cell death and inhibited the transition
from CD4CD8 (DN) to CD4+CD8+ (DP) stage up-
stream of the transcriptional factor p53 pathway.
The expression of Cdkn2A (the gene encoding
p19Arf) in immature thymocytes was directly regu-
lated by PcG complex containing Bmi-1 and M33
through the maintenance of local trimethylated his-
tone H3K27. Our results indicate that this epigenetic
regulation critically contributes to the survival of the
activated pre-T cells, thereby supporting their prolif-
eration during the DN-DP transition.
INTRODUCTION
Thymocytes undergo two massive expansions before T cell
receptor (TCR) b and a gene rearrangement for TCR diversifica-
tion, and the control of the cell cycle and cell survival are essen-
tial for the appropriate cell expansion of thymocyte population.The least mature double-negative (DN) CD4CD8 thymo-
cytes can be divided into four sequential subpopulations
(DN1-4) according to the expression of CD44 and CD25:
CD44+CD25 (DN1), CD44+CD25+ (DN2), CD44CD25+ (DN3),
and CD44CD25 (DN4). DN4 cells give rise to double-positive
(DP) CD4+CD8+ cells and subsequently mature into CD4+ or
CD8+ single-positive (SP) cells.
The first cell expansion occurs during DN1 to DN3 before
TCRb gene rearrangement (pre-b proliferation), and the second
occurs during the DN-DP transition before TCRa gene rear-
rangement (pre-a proliferation) (Fehling and von Boehmer,
1997; Ikawa et al., 2004; Kawamoto et al., 2003). After pre-b pro-
liferation, T precursor cells stop proliferating and undergo gene
rearrangement at the TCRb locus. Pre-T cells with successful
functional TCRb chain gene rearrangement undergo pre-a prolif-
eration and differentiate into DP cells (von Boehmer et al., 2003).
In this process, they receive stage-specific growth signaling cell
autonomously and/or from thymic microenvironments (Garbe
and von Boehmer, 2007; Yamasaki and Saito, 2007). In these
expansions, the proper growth and differentiation of the cells
require not only the promotion of the cell cycle but also the
restraint of cell death, because activated cells are likely to be
more susceptible to damage than the resting cells. Although
the molecular mechanism of pre-TCR-induced proliferation has
been examined in detail (Michie and Zuniga-Pflucker, 2002;
Rothenberg and Taghon, 2005; Sun et al., 2000; Xi and Kersh,
2004; Yu et al., 2004), the mechanism of protection against cell
death during this proliferation phase has received little attention.
The genes encoding Polycomb group (PcG) proteins are
considered to constitute a class of regulatory genes responsible
for maintaining cell identity. Their protein products form multi-
meric protein complexes, which epigenetically maintain the
repressed state of target genes during multiple rounds of cell
divisions. Thus, PcG genes are thought to control cell fate,
cell differentiation, and cancer development (Valk-Lingbeek
et al., 2004; Sparmann and van Lohuizen, 2006). At least two
Polycomb complexes with distinct functions have been identi-
fied, termed Polycomb Repressive Complex 1 (PRC1) and 2
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Cdkn2a Repression by Bmi-1 during DN-DP Transition(PRC2). Mammalian PRC1, which competitively inhibits the SWI-
SNFchromatin-remodeling complex, consists ofBmi-1,MEL-18,
M33, PC2, Mph1/2, and RING1A/B, whereas EED, EZH1/2, and
SUZ12 are the core components of PRC2, which is involved in
the initiation of gene repression andhas catalytic activity in the tri-
methylation of histone H3 lysine 27 (3mH3K27) (Cao et al., 2002;
Czermin et al., 2002; Muller et al., 2002). The PRC1 complex can
recognize 3mH3K27 through thechromodomain ofM33, an inter-
action that has been proposed to target PRC1 to the appropriate
genomic locations (Fischle et al., 2003; Min et al., 2003).
We believe that this PcG-mediated epigenetic regulation plays
an essential role in T cell development because mice deficient in
PcG genes exhibit impaired T cell development (Akasaka et al.,
1997; Hosokawa et al., 2006; Kimura et al., 2001; Sato et al.,
2006; Su et al., 2005; van der Lugt et al., 1994). Certainly, among
the PRC1 genes,Mel-18-deficientmice show reduced number of
thymocytes to less than 5% of wild-type in spite of normal CD4
and CD8 profile, and Mel-18 has been shown to contribute
critically to pre-bproliferation bymaintaining the amount of Notch
signaling-induced Hes1 expression (Miyazaki et al., 2005).
Another coremember of PRC1 genes,Bmi1, is known to regulate
the self-renewal of hematopoietic stem cells (HSCs) (Iwama et al.,
2004; Park et al., 2003), and thymic cellularity is severely reduced
in adult Bmi-1-deficient mice (Jacobs et al., 1999; van der Lugt
et al., 1994). However, little is known about the stage at which
thymocyte development is affected and the role of the PRC1
complex, which contains Bmi-1, in thymocyte development.
The Ink4a-Arf tumor suppressor locus encodes two proteins,
p19Arf and p16Ink4, and influences key physiological processes
such as replicative senescence, apoptosis, and stem cell self-
renewal (Gil and Peters, 2006; Kamijo et al., 1997; Quelle et al.,
1995). The transcripts of two alternative first exons (exon 1b,
p19Arf; exon 1a, p16Ink4) are spliced to that of a shared second
exon, whose sequences are translated in two different reading
frames. p19Arf is induced by oncogenic stress and induces
cell-cycle arrest or apoptosis in a p53-dependent or -indepen-
dent manner whereas p16Ink4a regulates the cell cycle by inhib-
iting the cyclin-dependent kinases (CDK) (Gallagher et al., 2006;
Sherr, 2006). Bmi-1 and several other PcG proteins have been
implicated as regulators of the Ink4a-Arf gene locus during
senescence inmouse embryonic fibroblast (MEF) and neoplastic
development (Jacobs et al., 1999; Itahana et al., 2003; Smith
et al., 2003; Valk-Lingbeek et al., 2004). Although the disruption
of genes encoding both p16Ink4a and p19Arf may rescue the
impaired hematopoiesis and lymphocyte development observed
in Bmi1/ mice (Bruggeman et al., 2005; Jacobs et al., 1999), it
is still unclear which gene is involved in the defects of Bmi1/
thymocytes and whether its expression truly affects thymocyte
development. Moreover, little is known about whether the
transcriptional regulation of the Ink4a-Arf locus has any biologi-
cal significance in vivo besides tumor suppression, because the
expression of genes encoding p16Ink4a and p19Arf is low or
undetectable in normal mice (Zindy et al., 2003).
In this study, we found that Bmi-1 deficiency causes the death
of activated pre-T cells in ab T cell development and results in the
inhibition of the DN-DP transition, and these impairments are
caused by upregulation of p19Arf, not p16Ink4a. We found that
p19Arf overexpression results in thymocyte cell death and
inhibits the DN-DP transition in a p53-dependent manner. We
232 Immunity 28, 231–245, February 2008 ª2008 Elsevier Inc.further observed that the Rag1;Arf double-knockout mice could
produce DP thymocyte. The expression of p19Arf is directly
regulated by the Bmi-1 Polycomb complex through the mainte-
nance of 3mH3K27 at this locus in immature thymocytes. This
epigenetic maintenance system plays a critical role in thymocyte
development by restraining cell death during the pre-TCR-
induced proliferation phase.
RESULTS
Impaired Cell Expansion and Differentiation
of DN Thymocytes in Bmi1/ Mice
It was reported (Jacobs et al., 1999) and confirmed here
(Figure 1A, left) that the number of thymocytes in adult Bmi1/
mice was markedly reduced and the percentage of DN cells was
increased. However, the stage at which the thymocyte
development was affected was unclear. Therefore, we analyzed
thymocyte development in detail in Bmi1/mice. We found that
in the Bmi1/ mice, the percentage of DN3 cells was increased
while that of DN4 cells was decreased in lineage-negative DN
subpopulations (Linneg DN), resulting in a markedly decreased
DN4/DN3 ratio (Figure 1B, right). On the other hand, we found
an increased percentage of gd T cells in Bmi1/ thymus
(Figure 1A). Although the cellularity appeared to be normal in
Bmi1/ fetal thymocytes (FTs) at 15.5 days postcoitum (dpc),
the cell number was slightly reduced in the 17.5 dpc Bmi1/
FTs. These impairments were exacerbated after birth with aging
(see Figure S1 available online).
To further clarify which developmental stage was affected by
Bmi-1 deficiency, we analyzed the absolute cell number ratio
of Bmi1/ versus Bmi1+/ cells at each developmental stage.
The ratio in LinnegSca1+c-kithigh (LSK) cells was about 0.3,
whereas the ratios in DN1 and DN2 cells were less than 0.1.
Although the ratio in DN3 cells was 0.5, those in DN4 and
DP were markedly lower (<0.05) (Figure 1B). Here, we sup-
posed that Bmi1 deficiency might cause the differentiation ar-
rest of T precursor cells at the DN3 stage, in addition to the
decreased number of HSCs. To confirm this and to rule out
environmental effects, we performed coculture of T progenitor
cells isolated from adult Bmi1/ or control mice with dGuo-
treated fetal thymus (fetal thymus organ culture; FTOC). The
earliest T progenitor cells (ETPs) can be described as
CD44+CD25ckithigh (Allman et al., 2003), so we performed
FTOC by using ETPs. Compared with control cells, adult
Bmi1/ ETPs differentiated into DN3 cells (day 10) but ar-
rested at this stage (day 15 and day 20), and the reconstituted
cell number was remarkably decreased (Figure 1C). Similarly,
an impaired DN-DP transition was observed in FTOC with fetal
Bmi1/ ETPs (data not shown). Taken together, Bmi1 defi-
ciency affects the expansion of ab-lineage DN thymocytes
and their DN-DP transition, and these are attributable to
defects in the thymocyte itself.
Bmi1 Controls the Survival of Activated Pre-T Cells
Because the accumulation of DN3 cells suggested a defect in
b selection, we first investigated the DNA rearrangement at the
TCRb locus and the expression of pre-TCR components in the
DN3 cell population. No substantial differences were observed
in the genomic DNA analysis for DJb and VDJb rearrangements
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Cdkn2a Repression by Bmi-1 during DN-DP TransitionFigure 1. Impaired Cell Expansion and Defective Differentiation at the DN3 Stage in Adult Bmi1/ Mice
(A) Representative flow cytometric analyses of CD4 versus CD8 expression and TCR-g versus CD3 expression on total thymocytes (left) and of CD44 versus
CD25 expression on lineage (CD4, CD8, CD3, CD19, Mac1, Gr1, Ter119, NK1.1)-negative (Linneg) DN thymocytes (right) from 8-week-old male wild-type
littermate control (Bmi1+/+) and Bmi1/ mice. The total thymocyte numbers are shown beneath the FACS profiles. The numbers in the profiles indicate the
percentages of the corresponding T cell populations.
(B) The ratio of the absolute cell number in Bmi1/ versus littermate control mice for femur and tibia bone-marrow cells (BM) (LSK [LinnegSca-1+c-kithigh], 7R+
[LinnegSca-1+c-kit+IL-7R+], B220+, and Mac1+Gr1+), thymocytes (Thy) (DN1-4, DP, and CD4 or CD8SP), and splenocytes (Spl) or mesenteric lymph nodes cells
(MLN) (CD3+, CD4+, CD8+, and B220+) (left). The DN4/DN3 ratios in Bmi1/ and control mice are shown. Data represent the mean ± SD from three mice (right).
(C) DN1; ETPs (LinnegCD25CD44+c-kithigh) from adult Bmi1/ and control mice were sorted and incubated in hanging drop culture with dGuo-treated FT lobes
(25 cells/lobe) and maintained in a standard FTOC system. Cells were analyzed on days 10, 15, and 20. Representative flow cytometric analyses of CD44 versus
CD25 expression on day 10 and day 15 and of CD4 versus CD8 expression on day 15 and day 20 are shown (left). A graphical presentation of the number of viable
cells per lobe on days 10, 15, and 20 is shown (right). Data represent the mean ± SD of three lobes. Two independent experiments produced with similar results.and in intracellular TCRb expression (icTCRb) between Bmi1/
and control DN3 cells (Figure 2A; Figure S2A). The expression
of pre-Ta and intracellular CD33 (icCD33) was also normal inBmi1/ DN3 cells (Figure 2A; Figure S2B). The mRNA and
surface expression of IL-7R were not impaired in Bmi1/ DN3
cells (Figure S2B). These results suggested that the impaired
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Cdkn2a Repression by Bmi-1 during DN-DP Transitiondifferentiation of Bmi1/ DN3 cells was not caused by the
impairment of either pre-TCR formation or IL-7R expression.
Then, to analyze cell proliferation and cell death, we investi-
gated the cell growth rate and performed the TUNEL assay. A
higher proportion of cells in the S-G2-M phase and an increased
percentage of BrdU-positive cells were observed in Bmi1/
DN3 cells (Figures S2C and S2D). We found increased TUNEL-
positive cells in Bmi1/ thymus (Figure 2B). Because these
Figure 2. Increasing Susceptibility to Cell Death for Pre-T Cells, in Particular DN3b Cells, in Bmi1/ Mice
(A) Intracellular TCRb and CD33 staining in DN3 and DN4 thymocytes from littermate control (Bmi1+/+) or Bmi1/ mice. The data are representative of three
independent experiments.
(B) Frozen sections of 4-week-old Bmi1/ and littermate control (Bmi1+/+) thymus were processed for TUNEL assays (green). DAPI-labeled cell nuclei are blue.
The results are representative of two independent litters. Scale bar represents 50 mm.
(C) In vitro survival assay. Sorted DN3a (LinnegCD44CD25+CD27low) and DN3b (LinnegCD44CD25+CD27high) cells from 16.5 dpc fetal thymocytes (FTs) or
5-week-old adult thymocytes (ATs) were cultured in medium for various time intervals. The numbers of viable cells were determined by flow cytometry. Data
represent the mean ± SD of three wells. Two independent experiments produced similar results.
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Cdkn2a Repression by Bmi-1 during DN-DP TransitionTUNEL-positive cells were predominantly observed in the
subcapsular region, where DN3-DN4 and early DP cells primarily
exist, we hypothesized that activated DN3 cells with a functional
TCRb selectively underwent cell death in Bmi1/ thymus. To
test this, we performed in vitro analyses of cell survival. Because
it has been reported that CD27 is upregulated in activated DN3
cells with icTCRb (Taghon et al., 2006), DN3a (CD27low) and
DN3b (CD27+) cells isolated from 16.5 dpc fetal thymus or
5-week-old adult thymus were cultured in medium for various
periods of time and the surviving cells were analyzed. In FTs,
fewer surviving cells were observed at each point of time in
Bmi1/ DN3b cells, whereas the survival ratio of Bmi1/
DN3a cells was equivalent to that of control (Figure 2C, top). In
adult thymocytes, the survival ratio of Bmi1/ DN3b cells was
remarkably decreased even at early time points whereas that
of Bmi1/ DN3a was slightly decreased, compared to wild-
type littermate (Figure 2C, bottom). Collectively, Bmi1 is critically
required for the survival of activated pre-T cells, thereby enabling
their expansion and differentiation.
Upregulation of p19Arf but Not p16Ink4a Expression
in Bmi1/ DN3 Cells
Although the disruption of the Ink4a-Arf can rescue the neurolog-
ical defects and the impaired lympho-hematopoiesis in Bmi1/
mice (Jacobs et al., 1999; Smith et al., 2003; Bruggeman et al.,
2005), it is unclear whether Ink4a-Arf genes are actually ex-
pressed in Bmi1/ thymocytes. Because an increasing rate of
cell growth was observed in Bmi1/ DN3 cells (Figure S2C), we
assessed the expression of Cdkn2a genes encoding p16Ink4a
andp19Arf andseveral otherCDK inhibitor genes. Theexpression
of p19Arf mRNA and protein was elevated in Bmi1/ DN3 cells,
whereas the expression of gene encoding p16Ink4a was unde-
tectable (Figures 3A and 3C). We found upregulation of p19Arf
in each developing thymocyte population (Figure 3B), whereas
p16Ink4a expression was not detected in any of the Bmi1/
or wild-type thymocyte populations (data not shown). The ex-
pression of p19Arf also increased in the Bmi1/ FTs (data not
shown). In addition, an upregulation of Cdkn2b(p15Ink4b),
Cdkn2c(p18Ink4c), and Cdkn1a(p21cip) expression was also
observed in Bmi1/ DN3 cells (Figure 3A). From the results of
increase in the growth rate (Figure S2), we considered that the
upregulationof theseCDK inhibitor genesmight not haveaffected
the cell cycle in the Bmi1/ DN3 cells. Taken together, these
results suggested that the defective phenotype in Bmi1/ DN3
cells resulted from the upregulation of p19Arf expression.
Overexpression of p19Arf Affects the Thymocyte
Expansion and Differentiation
Next, to examine whether p19Arf upregulation affected thymo-
cyte development, we infected hematopoietic progenitor cells
with bicistronic retroviral vectors encoding p19Arf plus eGFP,
and we subjected them to FTOC. The percentage of GFP-
positive cells was markedly lower for p19Arf-expressing cells
compared with that of GFP-control cells in FTOC (Figure S3A,
left), despite their almost equivalent infective titers in 3T3 cells
(data not shown). The number of thymocytes and the percentage
of DP population (%DP) were also lower in the p19Arf-express-
ing cells (Figure S3A, right).To investigate the effects of p19Arf in vivo, we generated
transgenic (Tg) mice carrying the gene encoding p19Arf under
the control of the Lck proximal promoter. We detected increased
levels of p19Arf protein in Tg thymocytes (Figure S3B). In p19Arf
Tg mice, the number of thymocytes and percentage of DP was
drastically reduced, whereas the percentage of gd T cell was
increased. In the Linneg DN population, the percentage of DN4
cells was markedly decreased (Figure 4A; Figure S3C). These
results confirmed that p19Arf overexpression impaired both
thymocyte expansion and the DN-DP transition ex vivo and
in vivo, similar to defects in the Bmi1/ thymocytes.
p19Arf Deficiency Can Substantially Rescue
the Impaired Thymocyte Development Observed
in Bmi1/ Mice
To determine whether upregulation of p19Arf was the primary
reason for the impaired thymocyte development in the Bmi1/
mice, we generated double-knockout mice (Arf/Bmi1/)
(Kamijo et al., 1997). An increase ofmore than 25-fold in the num-
ber of thymocyteswas observed in theArf/Bmi1/mice com-
pared with the Bmi1/ mice. The abnormalities in the CD4 and
CD8 profile and the DN4/DN3 ratio observed in theBmi1/mice
were almost completely rescued in the Arf/Bmi1/ mice
(Figures 4B and 4C). These results are in line with previously
published data (Bruggeman et al., 2005). The absolute cell
number ratios in DN4 and DP cells in Arf/Bmi1/ mice were
markedly increased, whereas those ratios in LSK and hemato-
poietic lineage cells other than B cells in the bone marrow (BM)
remained low (around 0.3) (Figure 4C). This indicated that
p19Arf deficiency rescued the impaired lymphocyte develop-
ment but not the defects in HSC in the Bmi1/ mice.
To examine cell-autonomous effects of p19Arf deficiency, we
then performed coculture of adult Arf/Bmi1/ ETPs with
dGuo-treated fetal thymus, as seen in Figure 1C. The lack of
p19Arf almost completely rescued the defects in the pre-b prolif-
eration and theDN-DP transition in theBmi1/ETPs (Figure 4D).
Taken together, we confirmed that an upregulation of p19Arf
primarily affected thymocyte development in the Bmi1/ mice.
p19Arf Critically Controls the Immature Thymocyte Cell
Death Upstream of p53
Because increased numbers of TUNEL-positive cells were
observed in Bmi1/ thymus (Figure 2B), we hypothesized that
p19Arf overexpression may have induced thymocyte cell death.
To test this idea, we performed the Annexin-V assay and TUNEL
staining in p19Arf Tg mice. Compared with control mice, the
percentage of Annexin-V-positive cells was greater in p19Arf
Tg mice (Figure 5A). Similar to Bmi1/ thymus, more TUNEL-
positive cells were observed in the subcapsular area of p19Arf
Tg thymus (Figure 5B). On the other hand, few TUNEL-positive
cells were observed in Arf/Bmi1/ thymus (Figure 5C). Inter-
estingly, the percentage of Arf/Bmi1/ DN3 cells that were
in S, G2, and M phases also recovered to degree comparable
to that in control mice (Figure S4). It is well known that p19Arf
upregulates p53 activity and that p53 is involved in thymocyte
survival and the DN-DP transition (Michie and Zuniga-Pflucker,
2002). Therefore, to clarify the p53 dependency in the p19Arf
Tg mice, we crossed them with Trp53/ mice. The p53 defi-
ciency rescued the block at the DN-DP transition in p19Arf Tg
Immunity 28, 231–245, February 2008 ª2008 Elsevier Inc. 235
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Cdkn2a Repression by Bmi-1 during DN-DP TransitionFigure 3. p19Arf, not p16Ink4a, Is Highly Expressed in Bmi1/ DN3 Cells
(A) Semiquantitative RT-PCRs were performed with primers specific for each gene on cDNAs obtained from sorted DN3 cells from adult Bmi1/ or control mice.
As an internal control, the expression of Gapdh was investigated. The results are representative of two independent litters.
(B) Semiquantitative RT-PCRs of p19Arf and Gapdh mRNA in each thymocyte population. The expression of p16Ink4a mRNA was not be detected in any pop-
ulation as examined by RT-PCRs (344 cycles) combined with a Southern hybridization procedure (data not shown).
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Cdkn2a Repression by Bmi-1 during DN-DP Transitionmice (Figure 5D). These results suggested that p19Arf overex-
pression caused the death of immature thymocytes and inhibited
theDN-DP transition upstreamof p53 and that the increased sus-
ceptibility of Bmi1/ pre-T cells toward cell death was primarily
caused by upregulation of p19Arf. These results are in line with
previously publisheddata that p53deficiency couldpartly restore
the defects of Bmi1/ thymocytes (Bruggeman et al., 2005).
p19Arf May Act as a Sensor for an Aberrant Bypass
of b Checkpoint, Similar to p53
Induction of p53 deficiency in Rag1/ mice could produce some
DP cells (Jiang et al., 1996). Thus, we considered that T precursor
cells that bypassed b checkpoint were eliminated by a p53-
induced cell death pathway.Wespeculated that p19Arf has a sim-
ilar function during the DN-DP transition. ThemRNA expression of
p19Arf is reported to be low or undetectable in normal tissue
in vivo; however, it is detectable in adult thymus (Zindy et al.,
1997). We found that p19Arf mRNA expression was detected in
the DN fraction and was elevated in 15.5 dpc FTs or Rag1/
FTs (data not shown). To examine whether p19Arf inhibits the dif-
ferentiation into DP cells in Rag1/ mice, we generated Rag1;Arf
double-deficient mice (Rag1/Arf/). Although most of the
young adult Rag1/Arf/ mice did not contain any DP cells, we
could detect DP thymocytes in a few older Rag1/Arf/ mice
(Figure 6A). This indicated that p19Arf might be possibly involved
in the inhibition of aberrant bypass of b checkpoint in Rag1/
mice.
A previous report suggested that thymic epithelial cells (TECs)
fromRag1/miceweredevelopmentally and functionallydistinct
from wild-type TECs (Zamisch et al., 2005). Therefore, to further
assess the involvement of p19Arf, BM cells from Rag1/Arf/
mice (C57BL/6-Ly5.2) were infused into the recipient mice
(C57BL/6-Ly5.1) and analyzed 4 weeks after bone-marrow trans-
plantation (BMT). Around 20% of the Ly5.1neg/5.2+ cells were DP
cells in Rag1/Arf/ BMT mice, whereas few DP cells were
observed inRag1/BMTmice (Figure 6B). Also, we could detect
DP cells in all Rag1/Arf/ recipient mice. These results
suggested that p19Arf acts as a sensor for an aberrant bypass
of b checkpoint, similar to p53.
PRC1 Containing Bmi-1 Regulates p19Arf Expression
by Maintaining the Degree of 3mH3K27
at the Ink4a-Arf Locus
Because PcG complexes are known to regulate the expression
of target genes through histone modification and DNA CpG
methylation (Hernandez-Munoz et al., 2005; Kirmizis et al.,
2004; Negishi et al., 2007; Vire et al., 2006), we examined these
events at the Ink4a-Arf gene locus in Bmi1/ thymocytes. When
we examined DNA CpG methylation by bisulfite DNA sequenc-
ing, DNA hypomethylation was observed in the promoter regions
of both p19Arf and p16Ink4a in Bmi1/ and control thymocytes
(Figure S5). This result suggested that DNA methylation was not
involved in the regulation of p19Arf or p16Ink4a in thymocytes.We next investigated the status of acetylated histone H3 and
H4 as well as dimethylated H3K4 and dimethylated H3K9 as
measures of an activated and silenced status, respectively, in
the entire Ink4a-Arf gene locus by chromatin immunoprecipita-
tion (ChIP) assays. We designed a panel of more than 44 pairs
of primers covering a 25 kb region from 10 kb upstream of
exon 1b to exon 2 (Figure S6A). The degrees of H3 and H4
acetylation and H3K4 dimethylation in the promoter region of
exon 1b were high and equivalent in both Bmi1/ and control
thymocytes, whereas those in the promoter region of exon 1a
were low (Figure 7A). On the other hand, the degree of H3K9
dimethylation was low in the promoter region of exon 1b in
both the wild-type and mutant thymocytes. We used the pro-
moter region of the gene encoding G6PDH as active status to
evaluate our ChIP assay (Figure S6B).
Because 3mH3K27 is important for PRC1-mediated repres-
sion (Sparmann and van Lohuizen, 2006), we determined the
3mH3K27 status at this entire locus. The degree of 3mH3K27
was high at this entire locus in control thymocytes, whereas it
was substantially lower in the Bmi1/ thymocytes (Figure 7B).
These results suggested that Bmi-1 is required to maintain the
amount of 3mH3K27 at the Ink4a-Arf gene locus, and thereby
regulates p19Arf expression in developing thymocytes.
Bmi-1 and another PRC1 component, Phc2, were recently
shown to bind directly to p16Ink4a exon 1a and exon 2 in
MEFs (Isono et al., 2005; Kotake et al., 2007). It was unclear,
however, whether Bmi-1 binds to exon 1b in vivo to regulate
p19Arf expression. We performed a ChIP assay with Bmi-1 anti-
body with Linneg DN cells, because Bmi-1 protein was high in DN
cells but low or undetectable in DP cells (Figure S7A; Raaphorst
et al., 2001). Bmi-1 bound to exon 1b, exon 1a, exon 2, and the
intron between exon 1b and 1a, but not to exon 3 in normal Linneg
DN cells (Figure 7C; Figure S6C). We did not observe any Bmi-1
binding by using total thymocytes, inwhichmost of the cellswere
DP cells and the expression of Bmi-1 protein was low (Figure 7C,
right). The PRC1 protein M33, which directly binds to 3mH3K27
(Min et al., 2003), appeared to bind preferentially to these Bmi-1
binding regions in normal Linneg DN cells (Figure S6D).
Taken together, these results indicated that Bmi-1, together
with M33, binds directly to the Ink4a-Arf gene locus, in particular
to exon 1b, in immature DN cells to maintain local amounts of
3mH3K27. This epigenetic regulation of p19Arf is essential for
the restraint of the death of activated pre-T cells and critically
contributes to their expansion and differentiation into DP cells.
DISCUSSION
In this study, we demonstrate that Bmi-1 plays an essential role
in protection against the cell death of activated ab lineage pre-T
cells during their expansion phase through the repression of
p19Arf expression. The expression of p19Arf, but not that of
p16Ink4a, was upregulated in Bmi1/ thymocytes, and this
upregulation actually impaired the DN-DP transition and caused
the death of activated pre-T cells. In addition, we clarified that(C) Immunoblot blotting analysis (left). Proteins (30 mg) in lysates from Bmi1+/+, Bmi1+/, or Bmi1/ thymocytes were separated by SDS-PAGE and blotted with
p19Arf antibodies (lanes 1–3). Proteins from 3T3 fibroblast cells infected with retroviral vector (pMx) encoding p19Arf were used as a positive control (15 mg) (lane
4). Immunofluorescence staining of total thymocytes and DN3 cells with p19Arf antibodies (green) and Hoechst (blue) (right). The results are representative of two
independent litters. Scale bars represent 10 mm.
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Cdkn2a Repression by Bmi-1 during DN-DP TransitionFigure 4. p19Arf Is the Principal Cause of the Defects in Bmi1/ Thymocytes and Impairs the DN-DP Transition
(A) Analysis of p19Arf Tg mice. The total thymocyte numbers are shown on the left. A representative flow cytometric analysis of CD4 versus CD8 expression on
total thymocytes and of CD44 versus CD25 expression on Linneg DN thymocytes from 6-week-oldmale p19Arf Tgmice (p19Arf Tg) and littermate control (WT) are
shown. The numbers in the profiles indicate the percentages of the corresponding T cell populations. The results are representative of two independent p19Arf Tg
mouse lines.
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Cdkn2a Repression by Bmi-1 during DN-DP Transitionp19Arf may act as a sensor for the aberrant bypassing of the
b checkpoint, similar to p53. Bmi-1 directly regulates p19Arf ex-
pression together with M33 through its binding to the Ink4a-Arf
locus, especially toward exon 1b, to maintain the local amounts
of 3mH3K27 in immature DN thymocytes. Our results reveal that
PRC1 containing Bmi-1-mediated epigenetic maintenance
system is required for the proliferation and differentiation of
pre-T cells activated by pre-TCR signaling through the restraint
of cell death (Figure 7E).
The Bmi-1 protein could be detected in Linneg DN cells
(Figure S7A; Raaphorst et al., 2001). The expression of Bmi1
mRNA was upregulated in DN2-DN4 cells during DN stage and
downregulated in DP stage. Bmi1 expression in gd cells was
equivalent to that in mature ab cells (Figure S7B).
During the DN-DP transition, the control of cell growth is
strongly inter-related with cell survival. For instance, in RORgt-
deficient and Egr3 Tg mice, the status of both cell cycling and
cell death were increased during the period from the immature
single-positive to the DP phase, the terminal stage of the
DN-DP transition. Interestingly, treatment with a CDK inhibitor
can avoid cell death in both mouse strains, and crossing them
with Bcl-xL Tg mice restores cell death and even the cell-cycle
phenotype (Sun et al., 2000; Xi and Kersh, 2004). We observed
more TUNEL-positive cells in subcapsular region and increased
susceptibility of DN3b cells toward cell death in Bmi1/ mice.
These findings demonstrate that, in the initiation of the DN-DP
transition, the epigenetic regulator Polycomb gene Bmi1 is
essential for the survival of pre-T cells activated by pre-TCR
signaling. Interestingly, DN3b cells, which resume cell prolifera-
tion before differentiating into the next stage, are highly affected
by Bmi-1 deficiency, unlike the effects of Bmi-1 in HSCs activity,
for which cell proliferation is tightly restricted and an undifferen-
tiated state is maintained.
Upregulation of p19Arf was found in Bmi1/ thymocytes,
whereas we could not detect the p16Ink4 expression. Further-
more, p19Arf deficiency alone rescued the impaired thymocyte
development and restored the number of B cells in the BM and
Spl in Bmi1/mice. Taking these results together, we conclude
that the defects in Bmi1/ thymocytes mainly resulted from
p19Arf dysregulation, whereas p16Ink4a was not involved. Con-
sistent with previous reports that p16Ink4a, but not p19Arf, was
associated with the loss of self-renewing HSCs in Bmi1/ mice
(Oguro et al., 2006), the absolute cell number of LSKs in BM was
not rescued in the Arf/Bmi1/ mice. Therefore, we suggest
that Bmi-1 plays a key role in the regulation of p19Arf expression
in T and B cell development whereas it is required for the repres-
sion of p16Ink4a in HSCs. This is in line with the recently
described differential effects of p19Arf and p16Ink4a in different
organs in Bmi1/mice (Bruggeman et al., 2005). p19Arf causes
cell-cycle arrest through a mechanism distinct from that medi-ated by the Ink4 family and is transcribed from its own promoter;
exon 2 is translated in a different reading frame to that used for
p16Ink4a (Quelle et al., 1995); and the evolution of p19Arf gene
is considered to be distinct from that of Ink4 genes (Gil and
Peters, 2006; Gilley and Fried, 2001; Kim et al., 2003). Collec-
tively, we consider that Bmi-1 and PcG is involved in controlling
the amounts of expression of both genes, whereas other mech-
anisms determine the onset of expression of each gene in a
developmental stage-specific manner, thereby contributing to
their biological functions.
p19Arf interacts with the MDM2 and ARF-BP1(Mule) to induce
p53 activation, leading to cell-cycle arrest and/or apoptosis.
p19Arf also has antiproliferative and apoptotic activities that
are p53 independent. In this study, we conclude that, in
Bmi1/ thymocytes, the upregulation of p19Arf led to cell death,
not inhibition of proliferation. In p19Arf Tg mice, p53 deficiency
could rescue its defects but not completely. In addition, when
we infected p53-deficient hematopoietic progenitor cells with
p19Arf-retrovirus and subjected them to FTOC, p53 deficiency
scarcely restored the defects in p19Arf-expressing cells (data
not shown). These results are in line with the previous study
that p53 deficiency could partly restore the defects of Bmi1/
thymocytes, including the CD4 and CD8 profiles (Bruggeman
et al., 2005). Here, we conclude that during thymocyte develop-
ment, p19Arf is upstream of p53 and can inhibit differentiation
and cause cell death of thymocytes in both p53-dependent
and -independent manners.
Previous reports have suggested that NF-kB activation by
pre-TCR signaling is required for the survival and differentiation
of developing pre-T cells with productive b-chain rearrange-
ments (Voll et al., 2000), and p19Arf inhibits the antiapoptotic
activity of NF-kB independently of p53 in cancer cells (Rocha
et al., 2003, 2005). In addition, we observed that overexpression
of p19Arf inhibited the pre-TCR signaling-induced proliferation
and differentiation of pre-T cells and that enhanced expression
of TCR could not restore the p19Arf-mediated inhibition (our
unpublished data). Collectively, we assumed that only pre-T
cells, which express a functional pre-TCR and downregulate
p19Arf expression, enter the DP stage (Figure S8). Pre-TCR sig-
naling could downregulate the p19Arf expression and increase
the amount of 3mH3K27 in its promoter region but could not
recruit the binding of Bmi-1 to the p19Arf promoter region
when we stimulated 17.5 dpc Rag1/ FTs with anti-CD33 (our
unpublished data). Therefore, the repression of p19Arf by
PRC1 containing Bmi-1 during the DN-DP transition appeared
to be controlled by other mechanisms. Notch signaling is essen-
tial for the DN-DP transition independent of pre-TCR activation
(Ciofani and Zuniga-Pflucker, 2005; Maillard et al., 2006). More-
over, in Notch1 and RBP-J conditionally deficient mice, ab T cell
development, not gd T cell development, was preferentially(B) Representative flow cytometric analyses of CD4 versus CD8 expression on total thymocytes (left) and of CD44 versus CD25 expression on Linneg DN thymo-
cytes (middle) from 4-week-old male Arf/Bmi1/mice and littermate controls (Arf/Bmi1+/). Total thymocyte numbers are shown on the left. The DN4/DN3
ratios in Arf/Bmi1/ and littermate controls (Arf/Bmi1+/) are shown. Data represent the mean ± SD from three mice (right).
(C) The ratios of the absolute cell numbers in Arf/Bmi1/ versus littermate control (Arf/Bmi1+/) mice (open bars) are shown with those in Bmi1/ versus
control mice (filled bars) in BM, Thy, and Spl, as described in Figure 1B. The results are representative of two independent litters.
(D) ETPs cells (LinnegCD25CD44+c-kithigh) from 4-week-old Arf/Bmi1/ or littermate control (Arf/Bmi1+/) mice were sorted and incubated in hanging drop
cultures with dGuo-treated FT lobes (25 cells/lobe) and maintained in a standard FTOC system. Cells were analyzed on days 10, 15, and 20. Representative flow
cytometric analyses of CD44 versus CD25 expression on day 10 and of CD4 versus CD8 expression on day 20 are shown (left). The viable cell numbers per lobe
on days 10, 15, and 20 are indicated. Data represent the mean ± SD from four lobes (right).
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Cdkn2a Repression by Bmi-1 during DN-DP Transitionaffected (Tanigaki et al., 2004; Wolfer et al., 2002). Because the
percentage of gd T cells was increased in Bmi1/ thymocytes
(Figure 1A), we speculated that the regulation of p19Arf by Bmi-
1 might be associated with the activation of Notch signaling. In
fact, another PRC1memberMel-18 is required for the expansion
of T progenitor cells bymaintaining the Hes1 expression induced
by Notch signaling (Miyazaki et al., 2005). Future studies will
Figure 5. Upregulation of p19Arf Causes
Cell Death in Thymocytes
(A) Representative flow cytometric analyses of
Annexin-V and PI on total thymocytes from wild-
type and p19Arf Tg mice are shown.
(B and C) Frozen sections of thymuses from
wild-type (WT), p19Arf Tg, Arf/Bmi1+/, and
Arf/Bmi1/ mice were processed for TUNEL
assays (green). DAPI-marked nuclei are blue.
Scale bars represent 50 mm.
(D) Representative flow cytometric analyses of
CD4 versus CD8 expression on total thymocyte
from 17.5 dpc p19Arf Tg;Trp53+/, p19Arf;Trp53/,
or Trp53+/+ fetuses.
address the functional relationship be-
tween Bmi-1 (PcG) and Notch signaling.
The p19Arf promoter region may be
accessible by transcriptional activators
in thymocytes because the status of H3
and H4 acetylation in the exon 1b was
high even in control thymocytes. Bmi-1
is indispensable for the repression of
p19Arf through maintaining the local
amounts of 3mH3K27. In previous re-
ports, 3mH3K27 at the promoter of
HoxC13 was not affected in Bmi1/
MEF (Cao et al., 2005), whereas the
repression of p16Ink4a by Bmi-1 required
its direct binding and the EZH2-mediated
3mH3K27 in the promoter of exon 1a in
MEF (Bracken et al., 2007; Kotake et al.,
2007). Importantly, we reported here that
Bmi-1 and M33 bind widely around exon
1b, exon 1a, and exon 2, but not in exon
3, in freshly isolated DN cells. Interest-
ingly, consistent with the low expression
of Bmi-1 protein, its binding was not
observed in total thymocytes. Therefore,
the PRC1 containing Bmi-1 binds to
the Ink4a-Arf locus in a developmental
stage-specific manner, and the binding
around exon 1b is required for the regula-
tion of p19Arf expression in developing
thymocytes. How Bmi-1 is recruited to
exon 1b, however, remains unclear. A
recent report suggested that pRB family
proteins collaborated with Bmi-1 to re-
press p16Ink4a expression. Neither Bmi-
1 nor PRC2 bound to the p16Ink4a locus
in the absence of pRB proteins, indicating
that additional mechanisms are neces-
sary for the recruitment of Bmi-1 and PRC to the target gene
loci (Kotake et al., 2007). Thus, we believe thatmechanisms other
than pre-TCR signaling recruit Bmi-1 to the p19Arf locus and reg-
ulate p19Arf expression appropriately.With respect to 3mH3K27,
Ezh2 has an enzymatic activity that mediates this trimethylation.
The differentiation of Ezh2/ thymocytes was arrested at the
DN3 stage despite unaffected TCRb rearrangement, and the
240 Immunity 28, 231–245, February 2008 ª2008 Elsevier Inc.
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Cdkn2a Repression by Bmi-1 during DN-DP Transitionamount of 3mH3K27 was markedly reduced. Interestingly, when
Ezh2was removed at the DP stage, thymocyte differentiation and
the amount of 3mH3K27 were not affected (Su et al., 2005). We
consider that Ezh2 is required for the initiationof 3mH3K27 in early
developing thymocytes and that this trimethylation is essential for
the DN-DP transition, whereas Ezh2 is dispensable in themainte-
nance of 3mH3K27 in a later developmental stage, which was
consistent with our results. We assume that H3K27 is trimethy-
lated by the PRC2 containing Ezh2 in early progenitor cells and
maintained by the PRC1 containing Bmi-1 and M33 during the
DN stage.
We propose that Bmi-1 critically contributes to thymocyte
proliferation and differentiation by suppressing p19Arf expres-
sion and may function as a sensor of the premature cell activa-
tion by the induction of cell death. Because Bmi-1 and other
PcG genes are involved in tumorigenesis (Raaphorst, 2005;
Richie et al., 2002; Valk-Lingbeek et al., 2004), perturbation of
this surveillance systemmay be related to abnormal cell prolifer-
ation. Further understanding of the molecular basis of our pres-
ent findings may provide new insight into lymphomagenesis.
EXPERIMENTAL PROCEDURES
Mice
Bmi1/ mice were described previously (van der Lugt et al., 1994), and
animals used in this study were backcrossd to C57BL/6 more than 8 times.
p19Arf/ mice were described previously (Kamijo et al., 1997) and kindly
Figure 6. p19Arf Inhibits the Aberrant
Bypass of b-Checkpoint in Rag1/ Mice
(A) Representative flow cytometric analyses of
CD4 versus CD8 expression on total thymocytes
(top) and of CD44 versus CD25 expression on
Linneg DN thymocytes (bottom) from 16-week-
old male Rag1/Arf+/+, Rag1/Arf+/, and
Rag1/Arf/ mice. DP cells were detected in
only 2 of 12 Rag1/Arf/ mice. The total thymo-
cytenumbersareshownbeneath theFACSprofiles.
(B) BM cells (1 3 107) from 4-week-old Rag1/
Arf+/+orRag1/Arf/mice (C57BL/6-Ly5.2)were
injected into sublethally irradiated recipient mice
(C57BL/6-Ly5.1). Representative flow cytometric
analyses of CD4 versus CD8 expression on gated
Ly5.1/Ly5.2+ thymocytes 4 weeks after trans-
plantation are shown. The results are representa-
tive of three independent experiments, indicating
that DP cells were detected in Ly5.1/Ly5.2+
thymocytes in all nine Rag1/Arf/ recipient
mice.
provided by C.J. Sherr (St. Jude Children’s Hospi-
tal). Trp53/micewere kindly provided byM. Kat-
suki (Okazaki National Research Institute). C57BL/
6J(B6, Ly5.2) mice were obtained from CREA Ja-
pan, and B6 SJL Ptprca Pep3bBoyJ(B6 Ptprc,
Ly5.1) mice were obtained from the Jackson Lab-
ratory. The generation of p19Arf Tg mice occurred
via the following method. The mouse p19Arf cDNA
containing the coding region was cloned into the
BamHI site of Lck proximal promoter transgene
cassette vector based on the construction de-
scribed as previously (Allen et al., 1992). A frag-
ment containing the Lck proximal promoter, the
mouse p19Arf cDNA, and the human growth hormone gene was excised
and purified. The fragment was microinjected into pronuclei of fertilized eggs
of C57BL/6 mice. Transgenic mice were identified by Southern blot analysis
of the offspring’s tail DNAs. Two independent founders carrying the transgene
were identified. All mice were kept in accordance with the laboratory animal
science guidelines of Hiroshima University. For timed pregnancies, the day
of vaginal plug was counted as day 0.5.
Flow Cytometry and Antibodies
Single-cell suspensions from bone marrow, thymus, spleen, and mesenteric
lymph node were stained with monoclonal antibodies and second reagents.
FITC-, PE-, APC-, APC-Cy7, and biotin-labeled monoclonal antibodies were
purchased from BD PharMingen (San Diego, CA) (CD4, CD8a, CD33, CD44,
CD25, c-kit, Sca-1, CD45R/B220, CD19, Mac-1, Gr-1, Ter119, NK1.1,
CD45.2, CD45.1) or from eBiosciences (San Diego, CA) (CD4, CD33, CD127,
Ter119, CD27). Biotinylated antibodies were revealed with Streptavidin-
FITC, -PE, -CyChrome, or APC-Cy7 (BD PharMingen). Clone 2.4G2 anti-
CD32:CD16 was used to block Fc receptors. For intracellular staining, sorted
DN3 or DN4 cells were fixed with 2% paraformaldehyde and then permiabi-
lized with 0.5% saponin. FACS analysis was performed on a FACS Calibur
flow cytometer (Becton Dickinson), and data were analyzed with FlowJo
(TreeStar Inc., Ashland, OR) software. For cell sorting, all cells were stained
with biotinylated lineage markers, bound to streptavidin-magnetic beads,
and depleted of lineage-positive cells by MACS separation column (Milteny
Biotech GmbH, Bergisch Gladbach). The lineage-negative cells were then
stained with subsequent antibodies as described above. Cells were subse-
quently sorted with a FACS VantageSE (Becton Dickinson). Dead cells were
removed from analysis and sorting by staining with propodium iodide (PI)
(Sigma-Aldrich, St. Louis, MO). Reanalysis of the sorted cells indicated a purity
greater than 96% for each cell population.
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Cdkn2a Repression by Bmi-1 during DN-DP TransitionFigure 7. Bmi-1 Binds Directly to the Ink4a-Arf Gene Locus, and in Particular to Exon 1b, and Maintains Local 3mH3K27
(A and B) Total thymocyte populations from 3-week-old Bmi1/ and littermate control mice were used. Antibodies against acetylated histone H3 and H4, dime-
thylated histone H3K4 and H3K9, and trimethylated histone H3K27 were used in the ChIP assays. Real-time PCRs were carried out with primers for each
amplicon. Two independent experiments were performed with similar results.
(C) Linneg DN and the total thymocyte population from 4-week-old C57BL/6 mice were used for ChIP assays with antibodies against Bmi-1. Probes in which the
intensity in Bmi-1 was 3-fold more than that in IgG were defined as ‘‘+.’’Retroviral Production
pMXs containing an internal ribosomal binding sites (IRES) and green fluores-
cent protein (GFP) (pMXs-IG) (Kitamura et al., 2003) and Plat-E packaging cells
were kindly provided by T. Kitamura (University of Tokyo, Japan). cDNA frag-
ments of p19Arf gene was inserted into the EcoRI and XhoI sites of pMx-IG to
generate pMXs-p19Arf-IRES-GFP. These vectors were transfected into Plat-E
242 Immunity 28, 231–245, February 2008 ª2008 Elsevier Inc.to obtain the viruses with FuGENE 6 transfection reagent (Roche Diagnostics)
according to the manufacturer’s recommendations.
FTOC and Retroviral Transduction into Hematopoietic Progenitors
All liquid cultures were performed in RPMI1640 (Invitorogen, Carlsbad, CA)
plus 10% FCS for fetal thymus organ cultures (FTOC), 50 mM 2-ME (Nacalai
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Cdkn2a Repression by Bmi-1 during DN-DP Transitiontesque, Japan), 1 mM sodium pyruvate (Invitorogen), 13 nonessential amino
acid solution (Invitorogen), and antibiotics. DN1 cells (Linneg/CD25/CD44+/
c-kithigh) from adult Bmi1/ and control mice (Ly5.2) were sorted and incu-
bated in hanging drop culture with deoxy-guanosine (dGuo)-treated 15.5 dpc
fetal tThymic lobes (Ly5.1) overnight, and then maintained in standard FTOC.
Cells were analyzed on days 10, 15, and 20. FL cells obtained from 14.5 dpc
embryos (Ly5.2) were depleted of Ter119+, Gr1+, and CD19+ cells by magnetic
column separation (Miltenyi Biotec) and then cultured overnight in FTOC-Me-
dium with 10 ng/ml stem cell factor (R&D) and 50 U/ml IL-7 (Genzyme). Then,
the cells were washed, counted, and replated in 24-well plates in retroviral su-
pernatant (pMXs-IG or pMXs-p19Arf-IG) plus 10 mg/ml polybrene (Sigma), IL-
7, and SCF. Viruses were pelleted onto cells by spinning plates at 500 3 g for
60 min at 37C. After 4 hr, cells were aliquoted in FTOC-medium at 10,000
cells/well in Terasaki plates, and 1 deoxy-guanosine-treated (d-Guo) 15.5
dpc B6 Ptprc (Ly5.1) thymic lobe per well was added. The cells and lobes
were incubated as hanging drop cultures. After 24 hr, each lobe was trans-
ferred to standard FTOC conditions, fed weekly, and analyzed after 12 days.
PCR Analysis of TCRb Rearrangement
Genomic DNA was obtained from sorted DN3 cells with DNAzol Reagent
(Invitrogen). Primers were Db1, 50-TTATCTGGTGGTTTCTTCCAGC-30; Db2,
50-GCACCTGTGGGGAAGAAACT-30; Jb2.6, 50-TGAGAGCTGTCTCCTACTAT
CGATT-30; TCRb5.1, 50-GTCCAACAGTTTGATGACTATCAC-20; TCRb8.2, CC
TCATTCTGGAGTTGGCTACCC-30. PCR products were electrophoresed
through a 1.2% agarose gel and stained with ethidium bromide.
Cell-Cycle Analysis and BrdU Uptake
The amount of nuclear DNAwas determined PI staining as follows. Sorted DN3
cells were fixed in 50%ethanol at 4C for 30min and incubated in PBS contain-
ing 1mg/mlRNase (Sigma-Aldrich) at 37C for 20min. The cellswerewashed in
PBS, resuspended in PBS containing 100 mg/ml PI, and analyzed by a FACS
Calibur. For BrdU uptake, mice were injected with 1 mg BrdU (Sigma) twice.
Then, thymocytes were isolated 3 hr after first BrdU injection, and DN3 cells
were sorted and staining with anti-BrdU Ab (BD) and Hoechist. The BrdU-
positive cells among more than 550 cells were counted under microscopy.
TUNEL Assay
Freshly cut 5 mm sections were fixed with acetone at room temperature for
2 min. TUNEL reaction was performed on sections with In Situ Cell Death
Detection Kit, Fluorescein (Roche, Mannheim, Germany), according to the
manufacturer’s protocol. In brief, sections were fixed in 4% paraformaldehyde
in PBS for 10 min at room temperature, incubated in 0.1% Triton X-100, 0.1%
sodium citrate for 2 min at 4C, and then incubated in TUNEL reaction mixture
for 1 hr at 37C.
RT-PCR
Semiquantitative RT-PCR was performed on cDNAs obtained from sorted
DN3 cells (LinnegCD44CD25+c-Kit+) in adult Bmi1/ or littermate control
mice. Total RNA was isolated from indicated cells with Trizol Reagent (Invitro-
gen) and was reverse-transcribed with SuperScript III RT-PCR system (Invitro-
gen) with oligo(dT) primer. The sequences of the PCR primers were p16Ink4a,
50-CGCCCAACGCCCCGAACTCT-30; p19Arf, 50-GGGTCGCAGGTTCTTGGT
CACT-30; common antisense, 50-GCTAAGAAGAAAAAGGCGGGCT-30; INK
4b, 50-CCGACCCTGCCACCCTTACCA-30; 50-CAGATACCTCGCAATGTCAC
G-30; INK4C, 50-AGGAAAGGGGAAAAAGAGAAGCA-30; 50-AACGGACAGCC
AACCAACTAAC-30; INK4D, 50-GGTCCGCCGCCTTCTTCATCG-30; 50-CTCCC
ACTCCCTTCTTCAATG-30; P21CIP, 50-GCTGGAGGGCAACTTCGTCTGG-30;
50-CGTGGGCACTTCAGGGTTTTCT-30; P27KIP, 50-ATACGAGTGGCAGGAG
GTGGAG-30; 50-ATGGGGTGTCAGTTTTGTGTTC-30; P57KIP, 50-TCTGAGCA
GGGCGAGGAGTC-30; 50-CGAAAGGTCCCAGCCGAAGC-30; GAPDH, 50-G
TGAAGGTCGGTGTGAACGGAT-30; 50-CAGAAGGGGCGGAGATGATGAC-30.
Immunofluorescence
Total thymocyte or sorted DN3 cells were fixed with 4% paraformaldehyde,
permiabilized with 1% SDS/0.5% TritonX, and then stained with p19Arf
antibody (abcam) and Hoechist.Bone-Marrow Transplantation
Isolated BM cells from Rag1/Arf+/+ or Rag1/Arf/ mice (C57BL/6-Ly5.2)
were injected into the recipient mice (C57BL/6-Ly5.1) (n = 3) irradiated at
a dose of 3.0 Gy (C57BL/6-Ly5.1). 4 weeks after BMT, isolated thymocyte
were stained with Ly5.2, Ly5.1, CD4, and CD8 antibodies and analyzed with
FACS Calibur.
Chromatin IP
Chromatin immunoprecipitation (ChIP) assay with acetylated H3 and H4
(Upstate Biotechnology), dimethylated H3K9 (abcam), dimethylated H3K4
(Upstate Biotechnology), trimethylated H3K27 (Upstate Biotechnology), Bmi-
1 (Upstate Biotechnology), M33 (Katoh-Fukui et al., 2005), and control (Santa
Cruz, CA) antibodies was performed as previously described (Ye et al., 2001).
In brief, isolated total thymocytes from Bmi1/ and littermate control mice
were fixed with formaldehyde for 5 min at room temperature and then soluble
chromatin was immunoprecipitated with antibodies overnight. PCR was per-
formed with SYBR Premix Ex Taq for real-time PCR (Takara). The sequences
of the PCR primers are available on request. ChIP with Bmi-1 antibody (Up-
state Biotechnology) was performed as previously described (Kotake et al.,
2007). Purified Linneg DN cells or total thymocyte from 4-week-old C57BL/6
mice were treated with 1% formaldehyde for 15 min at room temperature
and were cell lysedwith cell lysis buffer on ice. After centrifugation, the cell pel-
lets were lysed by sonication with nuclear lysis buffer. After procedures men-
tioned above, PCR was performed with Go Taq Green Master Mix (Promega).
Supplemental Data
Eight figures are available at http://www.immunity.com/cgi/content/full/28/2/
231/DC1/.
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